Physician profile
Kami Hoss
NPI 1063574390
$6,499.41
in general payments reported to CMS, 2019-2025
8 companies · $175 in 2025
The $175 reported for 2025 was more than what a typical Orthodontics and Dentofacial Orthopedics provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $825 · 2020: $2,169 · 2021: $23.25 · 2022: $1,047 · 2023: $26.70 · 2024: $2,233 · 2025: $175.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,892 · Food and Beverage: $536 · Gift: $6.35.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,891.50 |
| Food and Beverage | $536.49 |
| Gift | $6.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| A-Dec, INC. | $3,180.41 | 2019-2022 | |
| Align Technology, INC. | $2,624.69 | 2019-2024 | Invisalign |
| Henry Schein, INC. | $407.71 | 2023-2025 | 3m, Ketac, 3m-Relyx Fiber Post Refill |
| Gc America INC. | $222.20 | 2022 | |
| American Orthodontics Corporation | $25.85 | 2025 | Master Series, Radiance, Empower-Ceramic |
| Philips North America LLC | $17.35 | 2022 | |
| Dentsply Sirona INC | $12.95 | 2019 | |
| Biolase, INC. | $8.25 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kami Hoss listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.